%0 Journal Article
%T Characterization of adverse cutaneous effects in the setting of enfortumab vedotin for metastatic urothelial carcinoma: A retrospective review.
%A Malik R
%A Xiang DH
%A Riew GJ
%A Sanchez-Melendez S
%A Afvari S
%A LeBoeuf NR
%A Nambudiri VE
%J J Am Acad Dermatol
%V 0
%N 0
%D 2024 Jun 21
%M 38909660
%F 15.487
%R 10.1016/j.jaad.2024.06.037